Home Nav
Nextech Invest Logo

William G. Kaelin

Alfred Scheidegger

William G. Kaelin MD is a professor in the Department of Medicine at the Dana-Farber Cancer Institute, Harvard Medical School, and associate director, Basic Science, for the Dana-Farber/Harvard Cancer Center. He is a member of the board of scientific advisors of the National Cancer Institute, USA, of the National Cancer Policy Board, Institute of Medicine, USA. Dr Kaelin serves as member of the board of directors of Eli Lilly and Company and the American Association for Cancer Research. He is involved with advisory provision to several oncology companies.



14.05. – 16.05.2018

Ghent, Belgium

  • 25.04.2018

    Blueprint Medicines to report first quarter 2018 financial...

  • 23.04.2018

    Autolus announces license agreement with UCL Business...

  • 17.04.2018

    Autolus announces presentation of preliminary data showing...


Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.


* Compulsory fields


Newsletter Registration

Your eMail have been successfully registered.